The researchers noted exceptional progress in the outcomes of quantitative MRI and neuropsychological testing. The researchers performed the tests after the ten participating patients underwent a treatment involving a programmatic and personalized therapy.
The new technique was named metabolic enhancement for neurodegeneration. The findings of the study are published in the journal Aging. The research was conducted by the Buck Institute for Research on Aging and the UCLA Easton Laboratories for Neurodegenerative Disease Research in cooperation with each other.
The research is significant because it is the first research that has independently suggested that Alzheimer's patients' memory can be reinstated. "All of these patients had either well-defined mild cognitive impairment (MCI), subjective cognitive impairment (SCI) or had been diagnosed with AD before beginning the program", said author Dale Bredesen, MD, a professor at the Buck Institute and professor at the Easton Laboratories for Neurodegenerative Disease Research at UCLA.
The therapy of Bredesen for restoring the memory of AD patients comes as monotherapies designed to treat the condition did not yield desired results.
According to a story published on the topic by NewsWise, "He is a professor of clinical biomedical science in the Charles E. Schmidt College of Medicine and a professor in the Christine E. Lynn College of Nursing at Florida Atlantic University. He also serves as the associate dean for clinical research in the Schmidt College of Medicine and medical director of the Louis and Anne Green Memory and Wellness Center at FAU."
Galvin has played an important role in developing a number of dementia screening tools, including the Quick Dementia Rating System (QDRS), AD8, a brief informant interview to translate research findings to community settings.